Risk management decisions in women with BRCA1 and BRCA2 mutations.

Introduction: Pathogenic mutations and variants of uncertain significance (VUS) occur in BRCA1/2 genes.

Methods: Records of women with a pathogenic mutation or VUS in BRCA1/2 treated between 2008 and 2017 were reviewed.

Results: One hundred and ten women were included.